Upstream Bio (UPB) Change in Account Payables (2023 - 2026)

Upstream Bio's Change in Account Payables history runs 4 years deep, the most recent figure standing at -$1.0 million for Q1 2026.

• In Q1 2026, Change in Account Payables fell 242.9% year-over-year to -$1.0 million; the TTM figure through Mar 2026 stood at -$3.0 million (down 189.98% YoY), while the FY2025 annual figure was -$1.3 million, down 163.51% from the prior year.
• Change in Account Payables was -$1.0 million for Q1 2026 at Upstream Bio, up from -$1.2 million in the prior quarter.
• In the past five years, Change in Account Payables ranged from a high of $3.7 million in Q2 2024 to a low of -$2.2 million in Q2 2025.
• Historically, Change in Account Payables has averaged $147700.0 across 4 years, with a median of -$394500.0 in 2024.
• The sharpest annual moves came in 2025 and 2026: Change in Account Payables soared 905.17% in 2025, then plunged 242.9% in 2026.
• A 4-year view of Change in Account Payables shows it stood at $1.8 million in 2023, then slumped by 149.57% to -$871000.0 in 2024, then slumped by 40.76% to -$1.2 million in 2025, then advanced by 17.13% to -$1.0 million in 2026.
• The last three Change in Account Payables figures came in at -$1.0 million (Q1 2026), -$1.2 million (Q4 2025), and $1.4 million (Q3 2025), per Business Quant data.